About Sphingosine 1-phosphate receptor 2
Sphingosine 1-phosphate receptor 2 (S1PR2) is a protein
from Homo sapiens identified by UniProt accession
O95136, 353 residues long.
MolForge cross-references it against 0 known binders and
323 disease associations.
Target properties
| Protein name | Sphingosine 1-phosphate receptor 2 |
| UniProt accession | O95136 |
| Gene | S1PR2 |
| Organism | Homo sapiens |
| Length | 353 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (323)
Diseases linked to this target (Open Targets).
- multiple sclerosis · score 0.60
- relapsing-remitting multiple sclerosis · score 0.59
- reticulocyte count · score 0.55
- reticulocyte measurement · score 0.53
- deafness · score 0.53
- hearing loss, autosomal recessive · score 0.52
- monocyte count · score 0.51
- leukocyte count · score 0.45
- neutrophil count · score 0.40
- serum alanine aminotransferase measurement · score 0.38
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95136-F1 | alphafold | PREDICTED | 82.56 | — |
Amino-acid sequence (353 residues)
MGSLYSEYLN PNKVQEHYNY TKETLETQET TSRQVASAFI VILCCAIVVE NLLVLIAVAR NSKFHSAMYL FLGNLAASDL LAGVAFVANT LLSGSVTLRL TPVQWFAREG SAFITLSASV FSLLAIAIER HVAIAKVKLY GSDKSCRMLL LIGASWLISL VLGGLPILGW NCLGHLEACS TVLPLYAKHY VLCVVTIFSI ILLAIVALYV RIYCVVRSSH ADMAAPQTLA LLKTVTIVLG VFIVCWLPAF SILLLDYACP VHSCPILYKA HYFFAVSTLN SLLNPVIYTW RSRDLRREVL RPLQCWRPGV GVQGRRRGGT PGHHLLPLRS SSSLERGMHM PTSPTFLEGN TVV
Explore Sphingosine 1-phosphate receptor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets